Concorde Asset Management, LLC Twist Bioscience Corp Transaction History
Concorde Asset Management, LLC
- $183 Million
- Q4 2024
A detailed history of Concorde Asset Management, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Concorde Asset Management, LLC holds 9,416 shares of TWST stock, worth $448,107. This represents 0.24% of its overall portfolio holdings.
Number of Shares
9,416
Previous 10,906
13.66%
Holding current value
$448,107
Previous $492,000
11.18%
% of portfolio
0.24%
Previous 0.28%
Shares
6 transactions
Others Institutions Holding TWST
# of Institutions
265Shares Held
65.9MCall Options Held
129KPut Options Held
35.9K-
Artisan Partners Limited Partnership Milwaukee, WI5.89MShares$280 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$276 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.6MShares$266 Million2.28% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$258 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$171 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.68B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...